G01N 2333/82
Translation products from oncogenes
G01N2333/82 (Translation products from oncogenes) appears on 172 US grants and 325 published applications in this corpus.
Search patents in G01N- Granted patents
- 172
- Published applications
- 325
- Assignees
- 203
- Inventors
- 681
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 13 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 2 |
| 2002 | 3 | 5 |
| 2003 | 3 | 14 |
| 2004 | 1 | 6 |
| 2005 | 6 | 8 |
| 2006 | 1 | 12 |
| 2007 | 5 | 5 |
| 2008 | 4 | 14 |
| 2009 | 5 | 10 |
| 2010 | 9 | 20 |
| 2011 | 3 | 18 |
| 2012 | 3 | 9 |
| 2013 | 2 | 8 |
| 2014 | 4 | 13 |
| 2015 | 4 | 28 |
| 2016 | 10 | 25 |
| 2017 | 5 | 23 |
| 2018 | 12 | 15 |
| 2019 | 8 | 15 |
| 2020 | 19 | 12 |
| 2021 | 6 | 14 |
| 2022 | 6 | 15 |
| 2023 | 6 | 10 |
| 2024 | 4 | 4 |
| 2025 | 7 | 11 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- T cell receptors recognizing HLA-CW8 restricted mutated KRAS7 Jul 2026US 12,673,981 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Test method of dividing blastic plasmacytoid dendritic cell neoplasm (BPDCN) into subtypes19 May 2026US 12,630,883 B2Japanese Foundation for Cancer Research
- Probe and method for detecting membrane-associated molecules in living cells5 May 2026US 12,618,828 B2
- Biomarker combinations for determining aggressive prostate cancer5 May 2026US 12,618,843 B2Minomic International Ltd.
- Method for rapid accurate dispensing, visualization and analysis of single cells28 Apr 2026US 12,613,244 B2Takara Bio USA, Inc.
- Anti-HER2 Antibodies and Immunoconjugates1 Oct 2026US 2026/0297214 A1Genentech, Inc.
- Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells1 Oct 2026US 2026/0298930 A1Takara Bio USA, Inc.
- Her2 s310f specific antigen-binding molecules17 Sep 2026US 2026/0274987 A1Chugai Seiyaku Kabushiki Kaisha
- Integrated decentralized identity-based system for wearable body-fluid detection, biochemical assaying, evidence-chain verification, triage routing, and lifelong health management with multi-modal confirmation20 Aug 2026US 2026/0243768 A1
- Anti-her2/trop2 antibodies and uses thereof25 Jun 2026US 2026/0176373 A1Bright Biologics LLC
Most cited
By later US patents
- Methods for eliciting or enhancing reactivity to HER-2/neu protein131US 5,869,445 AUniversity of Washington · 1999
- Methods and compositions for detecting human tumors119US 4,699,877 AThe Regents of the University of California · 1987
- Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated114US 5,801,005 AUniversity of Washington · 1998
- Cell analysis method using quantitative fluorescence image analysis104US 5,733,721 AThe Board of Regents of the University of Oklahoma · 1998
- Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated92US 5,726,023 AUniversity of Washington · 1998